AMY IZZETT: Open Payments
NPI 1518906387 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 33 payments from 14 companies in 2025. Trend: 2023 $386 · 2024 $302 · 2025 $863
Food & beverage: $763Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $191 |
| Gilead Sciences, Inc. | 2 | $152 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| PFIZER INC. | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Eisai Inc. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
Products named: Trodelvy, DARZALEX, TECVAYLI, KEYTRUDA, Lenvima, JEMPERLI, ENHERTU, PADCEV.
Industry payments across TN — which companies pay providers there.
